887 results on '"Baracos, Vickie E."'
Search Results
52. Perspectives of Health Care Professionals on Multimodal Interventions for Cancer Cachexia
53. Associations Between Objectively Measured Physical Activity and Quality of Life in Cancer Patients With Brain Metastases
54. 22 - What Therapies Are Effective in Improving Anorexia and Weight Loss in Cancer?
55. 23 - What Therapeutic Strategies Are Effective in Improving Anorexia and Weight Loss in Nonmalignant Disease?
56. Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant
57. Factors Associated With Practice of Multimodal Care for Cancer Cachexia Among Physicians and Nurses Engaging in Cancer Care.
58. Cancer-associated cachexia
59. Meeting the Amino Acid Requirements for Protein Anabolism in Cancer Cachexia
60. Rapid Standardized CT-Based Method to Determine Lean Body Mass SUV for PET—A Significant Improvement Over Prediction Equations
61. Adherence to combined exercise and dietary intervention in patients with gastrointestinal cancer undergoing neo-adjuvant therapy: an open-label, pilot, randomized controlled trial.
62. Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?
63. A Multi-Site, International Audit of Malnutrition Risk and Energy and Protein Intakes in Patients Undergoing Treatment for Head Neck and Esophageal Cancer : Results from INFORM
64. Muscle mass and association to quality of life in non‐small cell lung cancer patients
65. The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis
66. Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non–Small-Cell Lung Cancer
67. New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss
68. Reframing eating during chemotherapy in cancer patients with chemosensory alterations
69. Development of a new equation to estimate creatinine clearance in cancer patients
70. Muscle Wasting Is Associated With Mortality in Patients With Cirrhosis
71. The impact of cachexia on dietary intakes, symptoms, and quality of life in advanced cancer
72. Assessing dynamic change in muscle during treatment of patients with cancer: Precision testing standards
73. Cancer cachexia: A systematic literature review of items and domains associated with involuntary weight loss in cancer
74. Definition and classification of cancer cachexia: an international consensus
75. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia
76. Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist
77. Physiological and functional failure in chronic obstructive pulmonary disease, congestive heart failure and cancer: a debilitating intersection of sarcopenia, cachexia and breathlessness
78. Development and validation of questionnaires for eating‐related distress among advanced cancer patients and families.
79. Identification and management of cancer cachexia in patients: Assessment of healthcare providers' knowledge and practice gaps.
80. Aetiology, classification, assessment, and treatment of the anorexia-cachexia syndrome
81. Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis
82. Correlates of objectively measured sedentary behavior in cancer patients with brain metastases: an application of the theory of planned behavior
83. Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis
84. A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands
85. The head and neck symptom checklist©: an instrument to evaluate nutrition impact symptoms effect on energy intake and weight loss
86. Ectopic fat in liver and skeletal muscle is associated with shorter overall survival in patients with colorectal liver metastases
87. Is there a genetic cause of appetite loss?—an explorative study in 1,853 cancer patients
88. P‐selectin genotype is associated with the development of cancer cachexia
89. Learning to predict cancer-associated skeletal muscle wasting from 1H-NMR profiles of urinary metabolites
90. An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity
91. Acides aminés, protéines et pathologies néoplasiques : peu de données pour une question essentielle
92. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
93. Physical activity interests and preferences in palliative cancer patients
94. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation
95. Response Regarding: Thigh Ultrasound Used to Identify Frail Elderly Patients With Sarcopenia Undergoing Surgery: A Pilot Study
96. Bolus oral glutamine protects rats against CPT-11-induced diarrhea and differentially activates cytoprotective mechanisms in host intestine but not tumor
97. Management of Cancer Cachexia:ASCO Guideline
98. Contributors
99. What Medications Are Effective in Improving Anorexia and Weight Loss in Cancer?
100. What Therapeutic Strategies Are Effective in Improving Anorexia and Weight Loss in Nonmalignant Disease?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.